The NeurologyLive® clinical focus page on sleep disorders provides information about the latest FDA actions, clinical guideline updates, clinical trial findings, and interviews with physicians on conditions such as obstructive sleep apnea, cataplexy, narcolepsy, insomnia, excessive daytime sleepiness, and more. The page features podcasts, videos, and news stories about the latest in clinical care for these sleep disorders.
September 1st 2025
Here's some of what is coming soon to NeurologyLive® this week.
Prescribed Hypnotic Medications, Not Insomnia Diagnosis, Cause Increased Risk for Serious Falls
July 28th 2022Findings showed that, although risk for serious fall injury was not mitigated by insomnia diagnosis, individuals with active insomnia taking prescribed hypnotic medication may be a particularly high-risk subgroup.
FT218 Receives Tentative Approval for EDS, Cataplexy in Adults With Narcolepsy
July 20th 2022Expected to be marketed as Lumryz by Avadel Pharmaceuticals, the extended-release oral suspension sodium oxybate’s final approval is pending the disposition of the REMS patent listed in the FDA’s Orange Book.
Understanding Individual Risks, Improving Trial Designs for Sleep Disorders in Alzheimer Disease
July 7th 2022Ruth Benca, MD, PhD, a professor and the chair of Psychiatry & Human Behavior at Wake Forest School of Medicine, provided insight on the age- and sex-related differences in sleep disorders, and the needed research on the effects of therapeutics in older populations.
NeurologyLive® Top Expert Interviews: June 2022
July 7th 2022Expert clinicians offer their insight on the sleep disorder landscape, the state of mental health in pediatric migraine, an inaugural movement disorders congress, a novel stroke rehabilitation tool, and psychedelics in cluster headache.